Ankura Hospitals has secured Rs 165 crore in funding from the Asian Development Bank. This strategic investment will enhance its pediatric, maternity, and gynecology services, enabling the Hyderabad-based chain to expand its facilities and strengthen its presence in key cities across India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hmIAXlY
via...
KKR in talks to acquire US dental labs chain Leixir
Global investment firm KKR is in talks to acquire Leixir Dental Laboratory Group from Comvest Investment Partners at a valuation of $200-$250 million. Leixir, founded in 2013, offers various dental solutions and operates facilities in the US and India. Deloitte is advising on the sale process.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Aeon5HM
via...
From AI to Telemedicine: Digital skills every healthcare professional should learn
Digital skills are crucial for healthcare professionals, with growing fields like telemedicine, AI-driven diagnostics, and data analytics. Continuous learning in electronic health records, cybersecurity, and emerging technologies like 3D printing and robotics is vital for those seeking to stay relevant and succeed in the evolving healthcare landscape.
from...
Eli Lilly working on a heart drug that may benefit Indians: CEO David Ricks
Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, potentially reducing it by 85%-90%. With heart disease cases surging in India, this phase 3 trial drug promises significant cardiovascular benefits, requiring only once-a-year administration. It's crucial, given the rising heart...
47 drugs found 'not of standard quality' in February
The Central Drugs Laboratories identified 47 drug samples as 'not of standard quality' in February, while State Drugs Testing Laboratories found 56 similar samples. One drug from West Bengal was found spurious and made by an unauthorized manufacturer. Regular action is taken to remove such drugs from the market.
from Healthcare/Biotech-Industry-Economic...
Essential medicines will cost you a bit more from April 1
Beginning April 1, prices for essential drugs like painkillers, antibiotics, and anti-diabetic medicines will rise by 1.74%. The increase is based on the change in the wholesale price index. The pharmaceutical industry is pushing for higher price hikes to counterbalance increased input costs over recent years.
from Healthcare/Biotech-Industry-Economic...
Kedaara, TA Associates vie for minority stake in Sagent Pharma
Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Investment amounts are estimated between $150-200 million. Originally acquired by Ravi Penmetsa's Ellimist Singapore, Sagent specializes in generic injectables for the US market.
from Healthcare/Biotech-Industry-Economic...